Post My Press Release

Free Press Release Distribution

Author: rohit009 (Page 1 of 12)

Surgical Instrument Tracking System Market

Surgical Instrument Tracking System Latest Technology Advancement

Global Surgical Instrument Tracking System Market   – Overview

The Global Surgical Instrument Tracking System (IGRT) Market is growing exponentially owing to the the impact of the UDI regulation and rising need for inventory management are the major factor driving the Surgical Instrument Tracking System Market. The global surgical instrument tracking system market is expected to Grow at a CAGR of 18% during the forecasted period.

Company Analysis

Braun Melsungen AG, BD, Censis Technologies, Inc., Xerafy, Haldor Advanced Technologies, Microsystems, Inc., Applied Logic, Inc., Infor, Intelligent InSites, Key Surgical, Mobile Aspects Inc., STANLEY Healthcare, TGX Medical Systems, Vizbee RFID Solutions, Roboz Surgical Instrument Co., JJ International Instruments, GEISTER MEDIZINTECHNIK GmbH, ESI, Millennium Surgical Corp and Katalyst Surgical, LLC and others are some of the prominent players at the forefront of competition in the Global Surgical Instrument Tracking System Market and are profiled in MRFR Analysis.

Segments:

Global Surgical instrument tracking system market has been segmented on the basis of types which include electronic tracking, barcode tracking, Radio Frequency Identification (RFID) and others. On the basis of end users which consists of hospitals, clinics, research facilities, laboratories and others. On the basis of component which consists of software, services and others.

Brows Complete Premium Research at https://www.marketresearchfuture.com/reports/surgical-instrument-tracking-system-market-1391

Regional Analysis of Surgical Instrument Tracking System Market:

Globally North America is the largest market for surgical instrument tracking system. The North American market for Surgical instrument tracking system is expected to grow at a CAGR of XX% and is expected to reach at US$ XXX Million by the end of the forecasted period. This is due to rising need for inventory management. Europe is the second-largest market for surgical instrument tracking system which is expected to grow at a CAGR of XX%. Whereas Asia pacific is expected to be a growing market for surgical instrument tracking system market

About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Embolic Protection Devices Market Highlights 2019

Embolic Protection Devices Market Highlights

Embolic protection devices are devices used to prevent or reduce plaque debris from reaching the distal bed during surgical procedures. They are commonly used in Saphenous Vein Graft (SVG) interventions and during carotid artery stenting procedures.

Global Embolic Protection Devices Market: Embolic Protection Devices: Increasing prevalence of rate in cardiovascular disorders is likely to drive the growth of the global market at a CAGR of 8.5% during 2018 to 2023.

Inquire for Sample Research Report https://www.marketresearchfuture.com/sample_request/5978

Industry Segmentation

The global embolic protection devices market is segmented on the basis of type, material, usage, application, and end-user.

On the basis of type, the market is segmented into distal filter devices, distal occlusion devices, and proximal occlusion devices.

On the basis of material, the market is segmented into nitinol and polyurethane.

On the basis of usage, the market is segmented into disposable devices and reusable devices.

On the basis of application, the market is segmented into cardiovascular diseases, neurovascular diseases, and peripheral vascular diseases. On the basis of cardiovascular diseases, it is further sub-segmented into coronary artery diseases, trans Cather aortic valve replacement, and saphenous vein graft diseases.

On the basis of the end-user, the market is segmented into hospitals and clinics, specialty centers, and ambulatory surgical centers.

Competitive Analysis by Major Key Players

  • Medtronic
  • Abbott Laboratories
  • Boston Scientific
  • Cordis
  • Contego Medical
  • Silk Road Medical
  • Claret Medical
  • Allium Medical Solutions
  • Angioslide
  • Claret Medical
  • Edwards Lifesciences Corporation

Intended Audience

  • Pharmaceutical Manufacturers and Suppliers
  • Medical Research Laboratories
  • Research and Development (R&D) Companies
  • Market Research and Consulting Service Providers
  • Potential Investors

Browse Complete Premium Research Report https://www.marketresearchfuture.com/reports/embolic-protection-devices-market-5978

Embolic Protection Devices Market Information: By type (Distal Filter Devices, Proximal Occlusion Devices), Material (Nitinol), Usage (Disposable Devices), Application (Cardiovascular Diseases), End-User (Hospitals & Clinics) – Global Forecast Till 2023.

About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar, Pune

+1 646 845 9312

Email: sales@marketresearchfuture.com

Brugada syndrome market Analysis and Research Report 2019

Brugada Syndrome Market Highlights

Factors such as the increasing prevalence of heart diseases and rising therapeutics demand are estimated to drive the market growth during the forecast period. Additionally, advancements in diagnostic technologies boost the market. However, low awareness and lack of healthcare services in the middle and low-income countries are estimated to restrain the market growth during the projected period.

The global Brugada syndrome market is expected to grow at a CAGR of 6.4% during the forecast period.

Brugada syndrome is a genetic condition resulting in an abnormal electrical activity within the heart, which in turn increases the risk of sudden cardiac death. In some cases, the abnormal heart rhythm often occurs when a patient is at rest and may be triggered by a fever. However, signs and symptoms of Brugada syndrome include fainting, irregular heartbeats or palpitations, and extremely fast and chaotic heartbeat. The signs and symptoms of Brugada syndrome are similar to some other heart rhythm related problems.

Inquire for Sample Research Report https://www.marketresearchfuture.com/sample_request/5849

Industry Segmentation

The global Brugada syndrome market is segmented on the basis of diagnosis, treatment, and end-user.

On the basis of diagnosis, the market is segmented into

  • electrocardiogram,
  • Electrophysiology (EP) test,
  • genetic testing,
  • and others.

On the basis of treatment, the market is segmented into

  • implantable cardioverter-defibrillator
  • and drug therapy.

Drug therapy is further segmented into Antiarrhythmic Drugs-

  • ajmaline,
  • allapinin,
  • ethacizin,
  • flecainide,
  • pilsicainide,
  • procainamide,
  • propafenone,
  • and others.

Psychotropic Drugs-

  • amitriptyline,
  • clomipramine,
  • desipramine,
  • lithium,
  • loxapine,
  • nortriptyline,
  • trifluoperazine,
  • and others.

Anesthetics/Analgesics-

  • bupivacaine,
  • procaine,
  • propofol,
  • and others.

On the basis of end-user, the market is segmented into hospitals and clinics, surgical centers, diagnostic centers, and others.

Competitive Analysis by Major Key Players

Some of the key players in this market are GeneDx (U.S), PGxHealth LLC (U.S), Abbott (U.S), GE Healthcare (U.K), Medtronic (U.S.), Pfizer, Inc (U.S), Boston Scientific Corporation (U.S.), GlaxoSmithKline (U.K), Eli Lilly Company (U.S), Taj Pharmaceuticals Ltd (India), and others.

Browse Complete Premium Research Report https://www.marketresearchfuture.com/reports/brugada-syndrome-market-5849

About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar, Pune

+1 646 845 9312

Email: sales@marketresearchfuture.com

Hallux Rigidus Market Growth Analysis Report- Forecast till 2023

Hallux Rigidus Market Research Report- Forecast till 2023 Highlights

Hallux rigidus is an arthritic condition often leading to pain and stiffness within the joint located behind the big toe. Hallux rigidus is a syndrome related to degeneration of the first MTP joint.  It leads to limitation in joint range of motion and painful ambulation.

The Global Hallux Rigidus Market is expected to grow at a CAGR of 7.6% during the forecast period.

Inquire for Sample Research Report https://www.marketresearchfuture.com/sample_request/5552

Industry Segmentation

The global hallux rigidus infection market is segmented on the basis of treatment, diagnosis, and end-users.

On the basis of the treatment, the market is segmented into non-surgical treatment and surgical treatment. Further, the non-surgical treatment is sub-segmented into shoe modifications, orthotic devices, medications, injection therapy physical therapy. And the surgical treatment is sub-segmented into bone spur removal (cheilectomy), joint fusion (arthrodesis), joint resurfacing (interpositional arthroplasty), and joint replacement (arthroplasty).

On the basis of diagnosis, the market is segmented into X-ray, CT scan, and MRI.

On the basis of the end users, the market is segmented into hospitals & surgical centers, home cares, and orthopedic specialty clinics.

Competitive Analysis by Major Key Players

Some of the key players in fungal eye infection market are DePuy Synthes Companies, Stryker, Zimmer Biomet, Smith & Nephew, Wright Medical Group N.V., Advanced Orthopaedic Solutions, Integra LifeSciences Corporation, and Acumed, Bioretec Ltd. among others.

Comprehensive Regional Analysis

The Americas dominate the global hallux rigidus market owing to the rising geriatric population, increase in genetic disorders and increasing number of surgical procedures in the hospitals. The Americas is further segmented into North America and South America. North America holds the largest market owing to extensive use of advanced technology and developed pharmaceutical sector.

Europe accounts for the second largest market due to increasing funds, government support, and increasing healthcare expenditure. For instance, according to Eurostat, Germany incurred healthcare expenditure over EUR 321 billion in 2014. Germany, France, and the U.K hold a significant share in the market due to increasing demand for technologically advanced devices for the surgical procedures and overall growth of medical device industry.

Browse Complete Premium Research Report https://www.marketresearchfuture.com/reports/hallux-rigidus-market-5552

About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar, Pune

+1 646 845 9312

Email: sales@marketresearchfuture.com

Pemphigus Market segmented into types, diagnosis, treatment and end users

Pemphigus Market Research Report – Forecast to 2023 Highlights

Pemphigus is a group of IgG-mediated autoimmune diseases of the skin and oral mucosa which causes blister and erosions on the skin. In pemphigus immune system mistakenly produces antibodies that attack healthy cells in skin and mucosa. Sometimes it may also occur due to a side effect of medication such as blood pressure drugs. Blisters that occurs on the skin may be referred to as flaccid bullae because they are not firm, and break opens easily.

The global pemphigus market is expected to grow significantly over the forecast period. It is estimated that the global pemphigus market is expected to register a CAGR of ~ 45% during the forecast period from 2018 to 2023.

Inquire for Sample Research Report https://www.marketresearchfuture.com/sample_request/6486

On the other hand, the lack of awareness regarding cancer and stringent regulation may hamper the growth of the market.

The global pemphigus market is dominated by many market players. The key players in the market are engaged in new launches and strategic collaborations to hold its market position.  

Industry Segmentation

The global pemphigus market has been segmented into types, diagnosis, treatment and end users. Based on types of pemphigus the market is further segmented into pemphigus vulgaris, pemphigus foliaceus, pemphigus vegetans, paraneoplastic pemphigus.

The market on the basis of diagnosis has been segmented into skin peeling, skin biopsy, run blood tests, endoscopy.

The market, by treatment, has been segmented corticosteroids, initial therapy, maintenance therapy

immunosuppressants, biological therapies, intravenous immunoglobulin (IVIG) therapy, other medication.

Based on end-user market is segmented into hospitals, clinics, laboratories.

Competitive Analysis by Major Key Players

Some of the key players in the global pemphigus market are Novartis Pharmaceuticals, Hoffmann-La Roche, Principia Biopharma, Inc, Argenx, Sanofi S.A., Pfizer Inc., Teligent Inc, GlaxoSmithKline LLC, and Teva Pharmaceutical Industries.

Browse Complete Premium Research Report https://www.marketresearchfuture.com/reports/pemphigus-market-6486

Comprehensive Regional Analysis

The Americas is anticipated to dominate the global pemphigus market. The market growth in this region is attributed to the increasing geriatric population with pemphigus disorder, investment in research and development and technological advancement. According to the US National Institute of Health 32 cases per million population were reported for pemphigus incidences in the US.

About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar, Pune

+1 646 845 9312

Email: sales@marketresearchfuture.com

conjugates vaccine market Synthesis and Research Report 2019

Conjugate Vaccine Market Highlights:

Conjugate vaccines are vaccines for infectious diseases. There are special polysaccharide coatings on some bacteria and viruses that help them to escape the immune system. An immature immune system can recognize these bacteria with the help of the conjugate vaccines, as these vaccines link the special polysaccharide coatings to an organism by producing immunity and response.

The global conjugates vaccine market is expected to grow at a CAGR of 10.5% during the forecast period 2017-2023.

The examples of conjugate vaccines are meningococcal vaccine to prevent meningitis, haemophilus influenzae type B (Hib) vaccine, and pneumococcal vaccine. According to the U.S. National Library of Medicine, National Institutes of Health, high mortality and morbidity are caused due to vaccine-preventable diseases. In 2010, 87% of the population of high-income countries had pneumococcal conjugate vaccines in their immunization schedules, whereas only 2% had pneumococcal conjugate vaccines in their immunization schedules among the total population of low-income countries.

Inquire for Sample Research Report https://www.marketresearchfuture.com/sample_request/4387

Comprehensive Regional Analysis

Globally, Conjugate vaccines market consists of four regions North America, Europe, Asia-Pacific and Middle East and Africa.

America is the largest market in the world due to the major initiatives taken by the government for vaccination against numerous diseases as well as excellent management of public awareness programs. Europe is the second largest market for conjugate vaccines which is expected to grow at an overwhelming CAGR during the forecast period. This is due to increasing research and development activities by pharmaceutical companies and research institutes.

In Europe availability of funds for research and development activities and growing emphasis on research for prevention measures of diseases is increasing.

Asia Pacific is the emerging market and is expected to grow rapidly during the forecasted period. India and China are leading countries in this region. Increasing population in developing economies is also driving growth of the market. Governments in developing countries of Asia-Pacific have undertaken various vaccinations programs. National Health Mission in India provide vaccination against meningitis, influenza.

The market shows steady growth in Middle East & Africa due to the demand of vaccine conjugates which is less than other regions across the globe.

Competitive Analysis by Major Key Players

GlaxoSmithKline plc. Merck & Co., Inc. (U.S), Fablife. (India), SutroVax Inc.(U.S), Sanofi Pasteur SA.(France), Pfizer (U.S), Sinovac Biotech Ltd. (China), IDT Biologics GmbH, GreenSignal Bio Pharma Limited (India), Taj Pharmaceuticals Limited (India), Bavarian Nordic(U.S) and others are some of the prominent players at the forefront of competition in the Global Conjugate vaccines Market and are profiled in MRFR Analysis.

Browse Complete Premium Research Report https://www.marketresearchfuture.com/reports/conjugate-vaccine-market-4387

The market is expected to show large opportunities in the coming future with the advancement of technology in developing countries and new products with increased accuracy. The effectiveness of vaccine conjugates and need more advanced research, which may hinder the growth of the market during the forecasted period. 

About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar, Pune

+1 646 845 9312

Email: sales@marketresearchfuture.com

Carcinoembryonic Antigen Market Growth According to Evolving Technology and Trends to 2023

Carcinoembryonic Antigen Market Highlights:

Carcinoembryogenic antigen (CEA) is a group of glycoproteins which are produced during the fetal developmental stages by gastrointestinal tissues. CEA is responsible for cell adhesion. Healthy adults do not have CEA concentrations. However, smoking and certain medical conditions such as colorectal cancer, breast cancer etc. can mark the presence of CEA in the body. Thus, CEA based diagnostic assays are used for the detection of such cancers and to check the treatment efficiency during the therapeutic period by a physician.

In 2017, studies of the NCBI suggested that the global burden of colorectal cancer will increase by 60%, leading to 2.2 million new cancer cases and 1.1 million deaths by 2030. This will increase the colorectal cancer diagnostic demands, thereby propelling the market growth.

Inquire for Sample Research Report https://www.marketresearchfuture.com/sample_request/772

Industry Segmentation

The global carcinoembryonic antigen market has been segmented on the basis of application, sampling, and end user.

Based on application, the market has been segmented into colorectal, pancreatic, breast, lung cancer, and others. 

Based on sampling, the market has been segmented into antecubital, peritoneal, pleural, serebrospinal, and others.

Based on the end users, the market has been segmented into hospitals, diagnostic centers, research centers, and others.

Competitive Analysis by Major Key Players

Some of key players profiled in the report are Lee BioSolutions, F. Hoffmann-La Roche Ltd, Quest Diagnostics Incorporated., Correlogic Systems, Inc, Genway Biotech, Inc., Abbott., RayBiotech, Inc., Abcam plc., Biocare Medical, LLC, and Biocare Medical, LLC

The report Global Carcinoembryogenic Antigen Market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.

Browse Complete Premium Research Report https://www.marketresearchfuture.com/reports/carcinoembryonic-antigen-market-772

Comprehensive Regional Analysis

The Americas account for the largest share in the carcinoembryogenic antigen market. The Americas mainly include countries like the U.S. and Canada. Increasing prevalence of cancer and high healthcare expenditures within the region will boost the market growth over the assessment period.

Europe is the second highest revenue generating region in the global carcinoembryogenic antigen market. Increasing prevalence of cancer, fast adoption of new technologies and presence of developed countries like Germany and U.K within the region will boost the market growth during the forecasted period.

On account of the developing medical infrastructure, rising healthcare expenditure, and increasing government initiatives, Asia Pacific region is expected to grow the fastest.

The Middle East & Africa is expected to grow slower than the global average. The Middle Eastern countries, for instance, UAE and Saudi Arabia dominates the market due to high income and the government support to improve public health.

Taste the market data and market information presented through more than 50 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content (TOC) & market synopsis on “Global Carcinoembryogenic Antigen Market” Research Report – Forecast till 2023.

About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar, Pune

+1 646 845 9312

Email: sales@marketresearchfuture.com

Liquid Handling System Market.j

Liquid Handling System Market Report 2019

Liquid Handling System Market Highlights:

The global liquid handling system market is anticipated to hold a market value of USD 2.95 billion in the year 2017 and is expected to grow at a CAGR of 8.7% during the forecast period. Liquid handling system is generally used in the pharmaceutical, life science, or biochemical laboratories. The liquid handling system can perform simple, monotonous routine tasks as well as complex pipetting task efficiently.

Currently, a large number of companies are engaged in developing liquid handling systems. For instance, Microlab VANTAGE, Microlab STAR, and Microlab NIMBUS are some liquid handling systems developed by Hamilton Company.

Inquire for Sample Research Report https://www.marketresearchfuture.com/sample_request/6588

Industry Segmentation

The global liquid handling system market has been segmented into type, product, application, and end user.

The global liquid handling system market, on the basis of type, has been segmented into manual, automated, and electronic liquid handling system. The electronic liquid handling system segment held the largest market share in 2017 due to the high accuracy and reproducibility offered by the electronic liquid handling system.

The global liquid handling system market, on the basis of product, has been segmented into pipettes, consumables, microplate reagent dispensers, liquid handling workstations, burettes, software, and others. The pipette segment has been segmented into manual pipettes, electronic pipettes, and semi-automated pipettes. The consumables segment has been segmented into disposable tips, tubes and plates, reagent containers, and others.

The global market, on the basis of application, has been segmented into drug discovery, genomics, clinical diagnostics, proteomics, and others. The drug discovery segment has been segmented into ADME screening, high-throughput screening (HTS), compound weighing and dissolution, and others. The genomics segment has been segmented into genotyping, next-generation sequencing (NGS), polymerase chain reaction (PCR), DNA/RNA purification, and others. The clinical diagnostics segment has been segmented into sample preparation, ELISA, and others.

The global market, by end user, has been segmented into pharmaceutical & biotechnology companies, contract research organization (CRO), and others.

Competitive Analysis by Major Key Players

Some of the prominent players in the global liquid handling system market are Agilent Technologies, Danaher Corporation, Thermo Fisher Scientific, Inc., Eppendorf AG, Tecan Group Ltd., Bio-Rad Laboratories, Sartorius AG, Mettler-Toledo International Inc., PerkinElmer, Inc., Corning Incorporated, and Hamilton Company.

Browse Complete Premium Research Report https://www.marketresearchfuture.com/reports/liquid-handling-system-market-6588

About Market Research Future: MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar, Pune

+1 646 845 9312

Email: sales@marketresearchfuture.com

Page 1 of 12

Powered by WordPress & Theme by Anders Norén